266. The representative of Brazil associated himself with the statement made by India and said that his delegation shared India's concern over the seizure of generic medicines in transit from and to developing countries through the European Union, especially as one of those cases had involved a shipment of Losartan Potassium bound for Brazil. His delegation's position on this issue had been set out repeatedly at the March and June 2009 sessions of the TRIPS Council and in other bodies within and outside the WTO. Although some contacts had been held with the European Commission, both in Brussels and in Geneva, no progress had so far resulted from those "opportunities for dialogue" and there had been no indication that the EC Regulation 1383/2003 might be reviewed in such a way that seizures of legitimate generics in transit could no longer take place on intellectual property grounds. The fact that the possibility of new seizures was still open remained a matter of grave concern for Brazil.
